SCHEMBL571576

SCHEMBL571576

COc1ccc(-c2coc3cc(OC)ccc3c2=O)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.84
RAB9A P51151 8/20 0.84
MAPT P10636 6/20 0.84
NPC1 O15118 6/20 0.84
ALDH1A1 P00352 4/20 0.84
SMN1; SMN2 Q16637 4/20 0.84
MEN1 O00255 4/20 0.84
KMT2A Q03164 4/20 0.84
KDM4E B2RXH2 3/20 0.84
CYP3A4 P08684 3/20 0.84
TP53 P04637 2/20 0.84
HPGD P15428 2/20 0.84
MAOA P21397 3/20 0.80
MAOB P27338 3/20 0.80
HSD17B10 Q99714 2/20 0.80
CYP2D6 P10635 2/20 0.80
CYP2C9 P11712 2/20 0.80
CYP2C19 P33261 2/20 0.80
BCL2 P10415 1/20 0.80
IL2 P60568 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814089 0.93 XDH (0.78) XDHRAB9AMAPTNPC1ALDH1A1
Isoformonentin SCHEMBL30105310 0.92 XDH (1.00) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL13774686 0.92 XDH (0.76) XDHRAB9AMAPTNPC1ALDH1A1
Isoformonentin SCHEMBL73338 0.92 XDH (1.00) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL12289033 0.92 XDH (0.76) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL22340136 0.92 XDH (0.76) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL762092 0.91 MAPT (1.00) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL10441792 0.90 MAPT (0.74) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL738941 0.89 ALDH2 (0.80) XDHRAB9AMAPTNPC1ALDH1A1
SCHEMBL30527918 0.89 ALDH2 (0.80) XDHRAB9AMAPTNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121577766-A Method, system and application for detecting adulteration in vegetable oil 长沙市食品药品检验所 2026-02-27 CN claimed
CN-111574489-B Synthetic method of 3',4', 7-trihydroxyisoflavone 中国人民解放军联勤保障部队第九〇四医院 2022-04-29 CN claimed
CN-111574490-B Synthesis method of polyhydroxy isoflavone 中国人民解放军联勤保障部队第九〇四医院 2022-04-29 CN claimed
CN-111574489-A Synthesis method of 3 ', 4', 7-trihydroxyisoflavone 中国人民解放军联勤保障部队第九〇四医院 2020-08-25 CN claimed
CN-111574490-A Synthesis method of polyhydroxy isoflavone 中国人民解放军联勤保障部队第九〇四医院 2020-08-25 CN claimed
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US claimed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP claimed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO claimed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US claimed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO claimed
US-20100041746-A1 NOVEL USE OF ORGANIC COMPOUNDS DSM IP ASSETS B.V. (NL) 2010-02-18 US claimed
EP-2019720-A2 TREATING MUSCULAR DISORDERS AND IMPROVING MUSCULAR FUNCTION DSMIP Assets B.V. (NL) 2009-02-04 EP claimed
WO-2007134867-A2 TREATING MUSCULAR DISORDERS AND IMPROVING MUSCULAR FUNCTION DSM IP ASSETS B.V. (NL) 2007-11-29 WO claimed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
CN-121577766-A Method, system and application for detecting adulteration in vegetable oil 长沙市食品药品检验所 2026-02-27 CN disclosed
CN-121577766-A Method, system and application for detecting adulteration in vegetable oil 长沙市食品药品检验所 2026-02-27 CN disclosed
US-20040068003-A1 Compounds useful for the inhibition of ALDH THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC, 2004-04-08 US disclosed
WO-2004002470-A1 COMPOUNDS USEFUL FOR THE INHIBITION OF ALDH THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) 2004-01-08 WO disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068003-A1 Compounds useful for the inhibition of ALDH ALDH2, ALDH1A1, ALDH3A1 XDH 108/4885RAB9A 2663/4885MAPT 4138/4885
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP XDH 2632/4885RAB9A 3143/4885MAPT 4313/4885
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL XDH 4695/4885RAB9A 409/4885MAPT 2113/4885
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 XDH 4441/4885RAB9A 4483/4885MAPT 2714/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 XDH 4441/4885RAB9A 4483/4885MAPT 2714/4885
US-20100041746-A1 NOVEL USE OF ORGANIC COMPOUNDS FABP2, FABP4, CPT1B XDH 289/4885RAB9A 3724/4885MAPT 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.